Intravaginal [spco]
dehydroepiandrosterone [horm, phsu, strd]
Prasterone [horm, phsu, strd]
Highly [qlco]
Efficient [qlco]
treatment [ftcn]
Dyspareunia [dsyn]
Methods [inpr]
Integral [qnco]
thi [euka]
prospective [resa]
randomized [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Phase III Clinical Trial [resa]
Study [mnob]
Effect [qlco]
Prasterone [horm, phsu, strd]
DHEA [horm, phsu, strd]
Applied [hlca]
Locally [spco]
Vagina [bpoc]
Severity [qlco]
Dyspareunia [dsyn]
postmenopausal [tmco]
Women [popg]
Identified [qlco]
Dyspareunia [dsyn]
Symptom [sosy]
vaginal atrophy [dsyn]
Meeting [hlca]
criteria [inpr]
Superficial [spco]
Cells [cell]
Thousand [qnco]
Currency [mnob]
Sign [fndg]
[pH] [qnco]
Screening [hlca]
Result [ftcn]
Integral [qnco]
Standard [qlco]
Duration [tmco]
weeks [tmco]
treatment [ftcn]
Increasing [ftcn]
Doses [qnco]
DHEA [horm, phsu, strd]
Decreased [qnco]
Percentage [qnco]
Parabasal cell [cell]
P NOS [aapp, imft]
placebo [topp]
Change [ftcn]
placebo [topp]
P NOS [aapp, imft]
effects [qlco]
Superficial [spco]
Cells [cell]
[pH] [qnco]
Highly significant [qlco]
Compared [acty]
placebo [topp]
DHEA [horm, phsu, strd]
Doses [qnco]
Severity score [qnco]
Pain [sosy]
Sexual Activity [bhvr]
Decreased [qnco]
Units [qnco]
placebo [topp]
DHEA [horm, phsu, strd]
Group [idcn]
P-Value [qnco]
placebo [topp]
Range [qnco]
Conclusions [idcn]
Integral [qnco]
Intravaginal [spco]
DHEA [horm, phsu, strd]
Local [spco]
Estrogen [horm, phsu, strd]
androgen formation [moft]
Rapid [qlco]
Highly [qlco]
Efficient [qlco]
Effect [qlco]
Pain [sosy]
Sexual Activity [bhvr]
Systemic [ftcn]
Exposure NOS [inpo]
Tissues [tisu]
Recently [tmco]
Reported [inpr]
Systemic [ftcn]
effects [qlco]
Estrogens [horm, phsu, strd]
